share_log

Quoin Pharmaceuticals Shares Are Trading Higher After the Company Announced It Received FDA Clearance to Initiate a New QRX003 Netherton Syndrome Clinical Study.

Benzinga ·  Dec 19, 2024 21:14
Quoin Pharmaceuticals Shares Are Trading Higher After the Company Announced It Received FDA Clearance to Initiate a New QRX003 Netherton Syndrome Clinical Study.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment